EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Thomas Walther
Friedrich W. Mohr
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walther, T.
Right arrow Articles by Mohr, F. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walther, T.
Right arrow Articles by Mohr, F. W.
Related Collections
Right arrow Cardiac - other
Right arrow Minimally invasive surgery
Right arrow Valve disease

Eur J Cardiothorac Surg 2007;31:4-6. doi:10.1016/j.ejcts.2006.11.001
Copyright © 2007, European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved


Editorials

Aortic valve surgery: time to be open-minded and to rethink

Thomas Walther, Friedrich W. Mohr*

Universität Leipzig, Herzzentrum, Klinik für Herzchirurgie, Strümpellstr. 39, 04289 Leipzig, Germany

* Corresponding author. Tel.: +49 341 865 1421; fax: +49 341 865 1452. (Email: mohrf@medizin.uni-leipzig.de).

The first 300 words of the full text of this article appear below.

Successful treatment strategies for cardiovascular diseases have often been initiated and driven by surgeons, which is true for both coronary artery and valvular heart diseases. Radical excision of diseased tissue, repair and replacement strategies lead to long-term successful treatment of the underlying diseases and clearly improved patient outcome. For many surgeons it was and may still be hard to understand that balloon dilation and stenting of severely diseased arteriosclerotic coronary arteries could be competitive for bypass surgery. The impact of all interventional strategies was underestimated by the surgeons, which lead to the overwhelming development of a new discipline of interventional cardiology. They further developed and steadily improved such strategies, heavily supported by medical industry, which lead to a steady growth of PCI, by far surpassing CABG surgery worldwide. Right now interventional cardiologists supported by some cardiac surgeons are on their way to transform some conventional open surgical procedures into catheter-based less invasive interventions, such as valve repair and replacement. Most of the surgeons react very conservatively and some get themselves involved to evaluate such techniques in order to have a fair comparison and control.

Conventional aortic and mitral valve replacement is a routine procedure that has been performed safely for decades. The majority of patients present with severely calcifying aortic valve stenosis, accounting for approximately 10–30% of cardiac surgical workload. Resection of all calcified tissue with subsequent prosthetic heart valve implantation using a standard suturing technique has been the only definitive therapy. Excellent haemodynamic outcome and functional results are achieved, and good long-term performance of conventional prostheses has been proven by numerous studies. Can similar results ever be accomplished by balloon dilation and stent based valve implantation without complete resection of the heavily calcified cusps? This is hard to believe for most surgeons since balloon dilation of aortic valve stenosis . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. Quaden, T. Attmann, M. Schunke, D. Theisen-Kunde, J. Cremer, and G. Lutter
Percutaneous aortic valve replacement: Endovascular resection of human aortic valves in situ.
J. Thorac. Cardiovasc. Surg., May 1, 2008; 135(5): 1081 - 1086.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Kostolny, V. Tsang, J. Nordmeyer, C. Van Doorn, A. Frigiola, S. Khambadkone, M. R. de Leval, and P. Bonhoeffer
Rescue surgery following percutaneous pulmonary valve implantation
Eur. J. Cardiothorac. Surg., April 1, 2008; 33(4): 607 - 612.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
T. Walther, V. Falk, M. A. Borger, and F. W. Mohr
Reply to Kalavrouziotis et al.
Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 189 - 190.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.